A Brief Overview of the Medicinal and Nutraceutical Importance of (chaga) Mushrooms

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Aug 22

PMID 39170453

Authors

Emma Camilleri

Renald Blundell

Bikash Baral

Tomasz M Karpinski

Edlira Aruci

Omar M Atrooz

Affiliations

Soon will be listed here.

Abstract

This literature review offers an extensive exploration of Chaga mushrooms (), focusing on their phytochemical composition, health-promoting attributes, and mechanisms of action. The aim was to provide an up-to-date overview of Chaga's significance in the medicinal sector, emphasizing its potential role in diverse health benefits. The review highlights Chaga's remarkable anticancer, antioxidant, anti-diabetic, anti-inflammatory, antimicrobial, and immunomodulating properties. By synthesizing recent findings, this work underscores Chaga's importance in the medicinal industries and provides valuable insights into its pharmacological potential.

References

Abugomaa A, Elbadawy M, Ishihara Y, Yamamoto H, Kaneda M, Yamawaki H . Anti-cancer activity of Chaga mushroom () against dog bladder cancer organoids. Front Pharmacol. 2023; 14:1159516. PMC: 10154587. DOI: 10.3389/fphar.2023.1159516. View

Handa N, Yamada T, Tanaka R . An unusual lanostane-type triterpenoid, spiroinonotsuoxodiol, and other triterpenoids from Inonotus obliquus. Phytochemistry. 2010; 71(14-15):1774-9. DOI: 10.1016/j.phytochem.2010.07.005. View

Blundell R, Camilleri E, Baral B, Karpinski T, Neza E, Atrooz O . The Phytochemistry of Species and their Medicinal Potentials. Am J Chin Med. 2023; 51(4):859-882. DOI: 10.1142/S0192415X23500404. View

Basal W, Elfiky A, Eid J . Chaga Medicinal Mushroom Inonotus obliquus (Agaricomycetes) Terpenoids May Interfere with SARS-CoV-2 Spike Protein Recognition of the Host Cell: A Molecular Docking Study. Int J Med Mushrooms. 2021; 23(3):1-14. DOI: 10.1615/IntJMedMushrooms.2021037942. View

Nakajima Y, Sato Y, Konishi T . Antioxidant small phenolic ingredients in Inonotus obliquus (persoon) Pilat (Chaga). Chem Pharm Bull (Tokyo). 2007; 55(8):1222-6. DOI: 10.1248/cpb.55.1222. View

Lee S, Hwang H, Yun J . Antitumor activity of water extract of a mushroom, Inonotus obliquus, against HT-29 human colon cancer cells. Phytother Res. 2009; 23(12):1784-9. DOI: 10.1002/ptr.2836. View

Kahlos K, Kangas L, Hiltunen R . Antitumor Activity of Triterpenes in Inonotus obliquus. Planta Med. 1986; (6):554. DOI: 10.1055/s-2007-969367. View

Wasser S, Weis A . Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol. 1999; 19(1):65-96. View

Sagayama K, Tanaka N, Fukumoto T, Kashiwada Y . Lanostane-type triterpenes from the sclerotium of Inonotus obliquus (Chaga mushrooms) as proproliferative agents on human follicle dermal papilla cells. J Nat Med. 2019; 73(3):597-601. DOI: 10.1007/s11418-019-01280-0. View

10.

Park Y, Won J, Kim Y, Choi J, Park H, Lee K . In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus. J Ethnopharmacol. 2005; 101(1-3):120-8. DOI: 10.1016/j.jep.2005.04.003. View

11.

Kim J, Yang S, Hwang A, Cho H, Hwang K . Composition of Triterpenoids in and Their Anti-Proliferative Activity on Cancer Cell Lines. Molecules. 2020; 25(18). PMC: 7570639. DOI: 10.3390/molecules25184066. View

12.

Maza P, Lee J, Kim Y, Sun G, Sung Y, Ponomarenko L . Inotodiol From Chaga Mushroom Induces Atypical Maturation in Dendritic Cells. Front Immunol. 2021; 12:650841. PMC: 7994266. DOI: 10.3389/fimmu.2021.650841. View

13.

Gery A, Dubreule C, Andre V, Rioult J, Bouchart V, Heutte N . Chaga ( Inonotus obliquus), a Future Potential Medicinal Fungus in Oncology? A Chemical Study and a Comparison of the Cytotoxicity Against Human Lung Adenocarcinoma Cells (A549) and Human Bronchial Epithelial Cells (BEAS-2B). Integr Cancer Ther. 2018; 17(3):832-843. PMC: 6142110. DOI: 10.1177/1534735418757912. View

14.

Zhao F, Xia G, Chen L, Zhao J, Xie Z, Qiu F . Chemical constituents from Inonotus obliquus and their antitumor activities. J Nat Med. 2016; 70(4):721-30. DOI: 10.1007/s11418-016-1002-4. View

15.

Jayachandran M, Xiao J, Xu B . A Critical Review on Health Promoting Benefits of Edible Mushrooms through Gut Microbiota. Int J Mol Sci. 2017; 18(9). PMC: 5618583. DOI: 10.3390/ijms18091934. View

16.

Park J, Nguyet Nguyen T, Park H, Thi Nguyen M, Lee N, Ban S . Protective Effects of Lanostane Triterpenoids from Chaga Mushroom in Human Keratinocytes, HaCaT Cells, against Inflammatory and Oxidative Stresses. Int J Mol Sci. 2023; 24(16). PMC: 10454022. DOI: 10.3390/ijms241612803. View

17.

Adamczak A, Ozarowski M, Karpinski T . Antibacterial Activity of Some Flavonoids and Organic Acids Widely Distributed in Plants. J Clin Med. 2020; 9(1). PMC: 7019947. DOI: 10.3390/jcm9010109. View

18.

Sulkowska-Ziaja K, Robak J, Szczepkowski A, Gunia-Krzyzak A, Popiol J, Piotrowska J . Comparison of Bioactive Secondary Metabolites and Cytotoxicity of Extracts from Isolates from Different Host Species. Molecules. 2023; 28(13). PMC: 10343780. DOI: 10.3390/molecules28134907. View

19.

Lee M, Kwon Y, Nam K, Kim S, Hwang I, Kim S . Chaga mushroom extract induces autophagy via the AMPK-mTOR signaling pathway in breast cancer cells. J Ethnopharmacol. 2021; 274:114081. DOI: 10.1016/j.jep.2021.114081. View

20.

Joo Y . Natural product-derived drugs for the treatment of inflammatory bowel diseases. Intest Res. 2014; 12(2):103-9. PMC: 4204705. DOI: 10.5217/ir.2014.12.2.103. View